Systane® lubricant eye drops in the management of ocular dryness
Umberto BenelliDepartment of Neurosciences, Section of Ophthalmology, University of Pisa, Pisa, ItalyAbstract: The understanding of dry eye disease has advanced recently through increasing recognition that the etiology of the condition involves both tear evaporation and insufficient tear production,...
Guardado en:
Autor principal: | Benelli U |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/448793201b744503a0a5eda672a1629a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
One month use of Systane® improves ocular surface parameters in subjects with moderate symptoms of ocular dryness
por: Piera Versura, et al.
Publicado: (2008) -
A randomized clinical evaluation of the safety of Systane® Lubricant Eye Drops for the relief of dry eye symptoms following LASIK refractive surgery
por: Daniel Durrie, et al.
Publicado: (2008) -
A Decade of Effective Dry Eye Disease Management with Systane Ultra (Polyethylene Glycol/Propylene Glycol with Hydroxypropyl Guar) Lubricant Eye Drops
por: Srinivasan S, et al.
Publicado: (2021) -
A two-week clinical evaluation of the safety of Systane® Ultra in contact lens-wearing patients
por: David Kading
Publicado: (2010) -
Effects of Systane® Balance on noninvasive tear film break-up time in patients with lipid-deficient dry eye
por: Aguilar AJ, et al.
Publicado: (2014)